Marco Hamins-Puertolas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Hamins-Puertolas has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Aaron Farmer
Department of Virology, WRAIR-Armed Forces Research Institute of Medical Sciences
5 shared publicationsDarunee Buddhari
Department of Virology, WRAIR-Armed Forces Research Institute of Medical Sciences
5 shared publicationsSopon Iamsirithaworn
Ministry of Public Health
5 shared publicationsTaweewun Hunsawong
Department of Virology, WRAIR-Armed Forces Research Institute of Medical Sciences
5 shared publicationsDerek A.T. Cummings
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University
4 shared publicationsDirek Khampaen
Ministry of Public Health, Tiwanond, Nonthaburi, Thailand
4 shared publications
Latest Publications
- Open Access
Applying a multiplex electrochemiluminescence NS1 assay to detect and differentiate Zika and dengue virus exposures in long-term community cohorts in Brazil and Thailand
Summary: Background: Distinguishing Zika virus (ZIKV) from Dengue virus (DENV) infection remains a major diagnostic challenge in co-endemic regions due to antigenic cross-reactivity. We evaluated a multiplex electrochemiluminescence Meso Scale Discovery System (MSD) NS1 assay to define ZIKV infection with high specificity across diverse immune backgrounds. Methods: We analyzed longitudinal samples from PCR-confirmed ZIKV and DENV infections across multiple cohorts, assessed correlations between MSD NS1 signal intensities and PRNT 50 titres, and performed ROC analyses to derive seroconversion thresholds. We then applied these criteria to identify ZIKV seroconversions in Brazil (2015-2024) and Thailand (2015-2025) Findings: ZIKV infections produced sustained NS1 responses, whereas primary DENV infections showed minimal ZIKV cross-reactivity and secondary DENV infections exhibited only transient, low-level increases. MSD NS1 signal intensities correlated with PRNT 50 titres for ZIKV and all four DENV serotypes (ρ = 0.54–0.84). ROC analyses identified a fold-change ≥ 10.96 as the optimal ZIKV seroconversion cutoff, with an AUC of 100% among DENV-naïve and 90.7% among DENV-exposed participants. Adding a second criterion — ZIKV/DENV fold-change ratio > 1 — further increased specificity. Application of this dual-threshold framework revealed high ZIKV incidence during the 2015–2016 epidemic in Brazil and very low incidence in the post-epidemic period. In the Thailand cohort, synchronous seroconversion among household members suggested potential intra-household transmission. Interpretation: The MSD NS1 multiplex assay provides a scalable, quantitative, and highly specific approach for identifying ZIKV infection and estimating seroincidence in co-endemic settings. The dual-threshold framework (fold-change ≥ 10.96 and ZIKV/DENV ratio > 1) enhances diagnostic precision, offering a robust tool for surveillance and transmission studies in flavivirus-endemic regions. Funding: Wellcome Trust Fund; The National Council for Scientific and Technological Development (CNPq; grant: 440891/2016–7, 311365/2021–3, and 303307/2026-9 to G.S.R.); the Bahia Foundation for Research Support (grant PET0022/2016 to G.S.R.); the Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education (grant 88881.130749/2016–01 to G.S.R.) RESEARCH IN CONTEXT: Evidence before this study: We searched PubMed, Scopus, and Web of Science for articles published in English up to May 1, 2026, using combinations of the terms “Zika virus”, “dengue virus”, “NS1”, “serology”, “cross-reactivity”, “electrochemiluminescence”, “multiplex assay”, “seroincidence”, and “PRNT”. Previous studies demonstrated that serological discrimination between Zika virus (ZIKV) and dengue virus (DENV) infections is challenging because of extensive flavivirus cross-reactivity, particularly in DENV-endemic settings. Conventional ELISA-based assays frequently lack specificity, especially among individuals with prior flavivirus exposure. Plaque reduction neutralization testing (PRNT) remains the reference standard for differentiating flavivirus infections, but its low throughput, high cost, and technical complexity limit its application in large epidemiological studies. Recent studies have highlighted NS1-based assays as promising alternatives because NS1 antibodies appear more virus-specific than envelope-directed responses. Multiplex electrochemiluminescence platforms, including Meso Scale Discovery (MSD), have shown high analytical sensitivity and scalability for infectious disease serology, but evidence supporting their use for distinguishing ZIKV from DENV infections across distinct immune backgrounds and longitudinal cohort settings remains limited. Few studies have evaluated quantitative seroconversion thresholds for identifying ZIKV infection in populations with prior DENV exposure or explored their application for long-term seroincidence estimation and transmission inference. Added value of this study: This study validates a multiplex electrochemiluminescence NS1 assay for differentiating ZIKV and DENV infections using multiple well-characterized cohorts from Brazil, Thailand, and the United States, including PCR-confirmed ZIKV and DENV infections, longitudinal community cohorts, and a controlled human dengue infection model. We identified a standardized serological threshold based on ZIKV NS1 fold-change (≥10·96) and demonstrated that combining this threshold with a second criterion—the ZIKV-to-DENV fold-change ratio > 1, substantially improves specificity in highly DENV-endemic populations. We additionally showed strong correlations between MSD signal intensities and PRNT 50 neutralization titres for ZIKV and all four DENV serotypes, supporting the use of the assay as a scalable surrogate for neutralization-based approaches. Application of this dual-threshold framework enabled estimation of ZIKV seroincidence over nearly a decade of follow-up in Brazil and identified patterns suggestive of intra-household transmission in Thailand. Together, these findings provide a practical high-throughput strategy for distinguishing flavivirus infections in epidemiological and surveillance settings. Implications of all the available evidence: Accurate discrimination between ZIKV and DENV infections remains a major barrier for flavivirus surveillance, seroepidemiological studies, and vaccine evaluation in co-endemic regions. Our findings suggest that multiplex NS1 electrochemiluminescence assays combined with quantitative dual-threshold criteria can provide a scalable and standardized alternative to PRNT for identifying ZIKV infections in populations with heterogeneous flavivirus exposure histories. This framework could strengthen surveillance systems by improving estimates of ZIKV seroprevalence and seroincidence, supporting detection of silent or low-level transmission, and enabling more reliable interpretation of longitudinal immune responses in endemic settings. The approach may also facilitate vaccine studies and outbreak investigations in regions where multiple flaviviruses co-circulate. Key messages: Strong and long-lasting ZIKV NS1 responses with minimal DENV cross-reactivity The Meso Scale Discovery System (MSD) multiplex NS1 assay measured robust and durable ZIKV-specific antibody responses following PCR-confirmed infection, while primary and secondary DENV infections produced only minimal or transient ZIKV NS1 reactivity, demonstrating high antigenic specificity. MSD NS1 signals correlate strongly with PRNT 50 neutralization titres Across multiple cohorts, MSD signal intensities showed strong concordance with PRNT 50 titres for both ZIKV and DENV serotypes, validating the MSD assay as a reliable, scalable surrogate for functional neutralization assays. A dual-threshold framework improves diagnostic accuracy ROC analyses identified a fold-change ≥ 10.96 as a sensitive and specific marker of ZIKV seroconversion, further refined by a ZIKV/DENV fold-change ratio > 1 to enhance specificity and reduce misclassification in DENV-exposed populations. Accurate detection of ZIKV seroincidence and transmission patterns Application of the dual-threshold criteria revealed high ZIKV incidence during the 2015–2016 epidemic in Brazil and very low transmission in subsequent years. In a Thai household, spatiotemporal clustering of seroconversion among three members is suggestive of intra-household transmission, demonstrating the framework’s utility for detecting potential transmission clusters in seroepidemiological surveillance.
Open AccessApplying a multiplex electrochemiluminescence NS1 assay to detect and differentiate Zika and dengue virus exposures in long-term community cohorts in Brazil and Thailand
Summary: Background: Distinguishing Zika virus (ZIKV) from Dengue virus (DENV) infection remains a major diagnostic challenge in co-endemic regions due to antigenic cross-reactivity. We evaluated a multiplex electrochemiluminescence Meso Scale Discovery System (MSD) NS1 assay to define ZIKV infection with high specificity across diverse immune backgrounds. Methods: We analyzed longitudinal samples from PCR-confirmed ZIKV and DENV infections across multiple cohorts, assessed correlations between MSD NS1 signal intensities and PRNT 50 titres, and performed ROC analyses to derive seroconversion thresholds. We then applied these criteria to identify ZIKV seroconversions in Brazil (2015-2024) and Thailand (2015-2025) Findings: ZIKV infections produced sustained NS1 responses, whereas primary DENV infections showed minimal ZIKV cross-reactivity and secondary DENV infections exhibited only transient, low-level increases. MSD NS1 signal intensities correlated with PRNT 50 titres for ZIKV and all four DENV serotypes (ρ = 0.54–0.84). ROC analyses identified a fold-change ≥ 10.96 as the optimal ZIKV seroconversion cutoff, with an AUC of 100% among DENV-naïve and 90.7% among DENV-exposed participants. Adding a second criterion — ZIKV/DENV fold-change ratio > 1 — further increased specificity. Application of this dual-threshold framework revealed high ZIKV incidence during the 2015–2016 epidemic in Brazil and very low incidence in the post-epidemic period. In the Thailand cohort, synchronous seroconversion among household members suggested potential intra-household transmission. Interpretation: The MSD NS1 multiplex assay provides a scalable, quantitative, and highly specific approach for identifying ZIKV infection and estimating seroincidence in co-endemic settings. The dual-threshold framework (fold-change ≥ 10.96 and ZIKV/DENV ratio > 1) enhances diagnostic precision, offering a robust tool for surveillance and transmission studies in flavivirus-endemic regions. Funding: Wellcome Trust Fund; The National Council for Scientific and Technological Development (CNPq; grant: 440891/2016–7, 311365/2021–3, and 303307/2026-9 to G.S.R.); the Bahia Foundation for Research Support (grant PET0022/2016 to G.S.R.); the Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education (grant 88881.130749/2016–01 to G.S.R.) RESEARCH IN CONTEXT: Evidence before this study: We searched PubMed, Scopus, and Web of Science for articles published in English up to May 1, 2026, using combinations of the terms “Zika virus”, “dengue virus”, “NS1”, “serology”, “cross-reactivity”, “electrochemiluminescence”, “multiplex assay”, “seroincidence”, and “PRNT”. Previous studies demonstrated that serological discrimination between Zika virus (ZIKV) and dengue virus (DENV) infections is challenging because of extensive flavivirus cross-reactivity, particularly in DENV-endemic settings. Conventional ELISA-based assays frequently lack specificity, especially among individuals with prior flavivirus exposure. Plaque reduction neutralization testing (PRNT) remains the reference standard for differentiating flavivirus infections, but its low throughput, high cost, and technical complexity limit its application in large epidemiological studies. Recent studies have highlighted NS1-based assays as promising alternatives because NS1 antibodies appear more virus-specific than envelope-directed responses. Multiplex electrochemiluminescence platforms, including Meso Scale Discovery (MSD), have shown high analytical sensitivity and scalability for infectious disease serology, but evidence supporting their use for distinguishing ZIKV from DENV infections across distinct immune backgrounds and longitudinal cohort settings remains limited. Few studies have evaluated quantitative seroconversion thresholds for identifying ZIKV infection in populations with prior DENV exposure or explored their application for long-term seroincidence estimation and transmission inference. Added value of this study: This study validates a multiplex electrochemiluminescence NS1 assay for differentiating ZIKV and DENV infections using multiple well-characterized cohorts from Brazil, Thailand, and the United States, including PCR-confirmed ZIKV and DENV infections, longitudinal community cohorts, and a controlled human dengue infection model. We identified a standardized serological threshold based on ZIKV NS1 fold-change (≥10·96) and demonstrated that combining this threshold with a second criterion—the ZIKV-to-DENV fold-change ratio > 1, substantially improves specificity in highly DENV-endemic populations. We additionally showed strong correlations between MSD signal intensities and PRNT 50 neutralization titres for ZIKV and all four DENV serotypes, supporting the use of the assay as a scalable surrogate for neutralization-based approaches. Application of this dual-threshold framework enabled estimation of ZIKV seroincidence over nearly a decade of follow-up in Brazil and identified patterns suggestive of intra-household transmission in Thailand. Together, these findings provide a practical high-throughput strategy for distinguishing flavivirus infections in epidemiological and surveillance settings. Implications of all the available evidence: Accurate discrimination between ZIKV and DENV infections remains a major barrier for flavivirus surveillance, seroepidemiological studies, and vaccine evaluation in co-endemic regions. Our findings suggest that multiplex NS1 electrochemiluminescence assays combined with quantitative dual-threshold criteria can provide a scalable and standardized alternative to PRNT for identifying ZIKV infections in populations with heterogeneous flavivirus exposure histories. This framework could strengthen surveillance systems by improving estimates of ZIKV seroprevalence and seroincidence, supporting detection of silent or low-level transmission, and enabling more reliable interpretation of longitudinal immune responses in endemic settings. The approach may also facilitate vaccine studies and outbreak investigations in regions where multiple flaviviruses co-circulate. Key messages: Strong and long-lasting ZIKV NS1 responses with minimal DENV cross-reactivity The Meso Scale Discovery System (MSD) multiplex NS1 assay measured robust and durable ZIKV-specific antibody responses following PCR-confirmed infection, while primary and secondary DENV infections produced only minimal or transient ZIKV NS1 reactivity, demonstrating high antigenic specificity. MSD NS1 signals correlate strongly with PRNT 50 neutralization titres Across multiple cohorts, MSD signal intensities showed strong concordance with PRNT 50 titres for both ZIKV and DENV serotypes, validating the MSD assay as a reliable, scalable surrogate for functional neutralization assays. A dual-threshold framework improves diagnostic accuracy ROC analyses identified a fold-change ≥ 10.96 as a sensitive and specific marker of ZIKV seroconversion, further refined by a ZIKV/DENV fold-change ratio > 1 to enhance specificity and reduce misclassification in DENV-exposed populations. Accurate detection of ZIKV seroincidence and transmission patterns Application of the dual-threshold criteria revealed high ZIKV incidence during the 2015–2016 epidemic in Brazil and very low transmission in subsequent years. In a Thai household, spatiotemporal clustering of seroconversion among three members is suggestive of intra-household transmission, demonstrating the framework’s utility for detecting potential transmission clusters in seroepidemiological surveillance.
- Open Access
- 27 May 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (22)
Long-term antibody dynamics challenge the paradigm of lifelong homotypic immunity to dengue virus
Immunity following infection with the four dengue virus serotypes (DENV1-4) remains difficult to define. Reports of individuals being reinfected with the same serotype challenge the paradigm that infection induces lifelong homotypic immunity. However, the frequency of these events and their importance for shaping immune profiles remain unknown. Here, we used data from three cohorts (N = 4,268 total participants) in two highly endemic settings (Cebu, Philippines, and Kamphaeng Phet, Thailand), which included long-term follow-up of individuals (mean follow-up of 8.8, 1.9, and 5.0 y). These data allowed us to elucidate age-specific patterns of infection and immunity, and to quantify individual long-term antibody titer dynamics following infection. We formulated mathematical models to explain these patterns, allowing for the possibility of progressive loss of immunity to homotypic reinfection. At the individual level, we found that, in the absence of subsequent infection, antibody titers exhibit a steady long-term decay following incident infections (half-life of 7 to 8 y), with the rate of decay slowing with increasing age. At the population level, incorporating homotypic reinfection was required to explain the age-specific dynamics of infection and immunity observed in our cohorts. We estimated that in highly endemic settings such as the Philippines, 60% of individuals have been homotypically reinfected by the age of 40 y. Our findings highlight homotypic reinfections as a key feature of endemic DENV settings and suggest that vaccines mimicking natural infection might not be expected to provide lifelong protection against infection.
- 27 May 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (22)
Open AccessLong-term antibody dynamics challenge the paradigm of lifelong homotypic immunity to dengue virus
Immunity following infection with the four dengue virus serotypes (DENV1-4) remains difficult to define. Reports of individuals being reinfected with the same serotype challenge the paradigm that infection induces lifelong homotypic immunity. However, the frequency of these events and their importance for shaping immune profiles remain unknown. Here, we used data from three cohorts (N = 4,268 total participants) in two highly endemic settings (Cebu, Philippines, and Kamphaeng Phet, Thailand), which included long-term follow-up of individuals (mean follow-up of 8.8, 1.9, and 5.0 y). These data allowed us to elucidate age-specific patterns of infection and immunity, and to quantify individual long-term antibody titer dynamics following infection. We formulated mathematical models to explain these patterns, allowing for the possibility of progressive loss of immunity to homotypic reinfection. At the individual level, we found that, in the absence of subsequent infection, antibody titers exhibit a steady long-term decay following incident infections (half-life of 7 to 8 y), with the rate of decay slowing with increasing age. At the population level, incorporating homotypic reinfection was required to explain the age-specific dynamics of infection and immunity observed in our cohorts. We estimated that in highly endemic settings such as the Philippines, 60% of individuals have been homotypically reinfected by the age of 40 y. Our findings highlight homotypic reinfections as a key feature of endemic DENV settings and suggest that vaccines mimicking natural infection might not be expected to provide lifelong protection against infection.
- Open Access
- 25 November 2025
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 21 (11) , e1013708
Linking multiple serological assays to infer dengue virus infections from paired samples using mixture models
Dengue virus (DENV) is an increasingly important human pathogen, with already half of the globe’s population living in environments with transmission potential. Since many cases are missed by direct detection methods (RT-PCR or antigen tests), serological assays play an important role in the diagnostic process. However, individual assays can suffer from low sensitivity and specificity and interpreting results from multiple assays remains challenging, particularly because interpretations from multiple assays may differ, creating uncertainty over how to generate finalized interpretations. We develop a Bayesian mixture model that can jointly model data from multiple paired serological assays, to infer infection events. We first test the performance of our model using simulated data. We then apply our model to 677 pairs of acute and convalescent serum collected as a part of illness and household investigations across two longitudinal cohort studies in Kamphaeng Phet, Thailand, including data from 232 RT-PCR confirmed infections (gold standard). We compare the classification of the new model to prior standard interpretations that independently utilize information from either the hemagglutination inhibition assay (HAI) or the enzyme-linked immunosorbent assay (EIA). We find that additional serological assays improve accuracy of infection detection for both simulated and real world data. Models incorporating paired IgG and IgM data as well as those incorporating IgG, IgM, and HAI data consistently have higher accuracy when using PCR confirmed infections as a gold standard (87–90% F1 scores, a combined metric of sensitivity and specificity) than currently implemented cut-point approaches (82–84% F1 scores). Our results provide a probabilistic framework through which multiple serological assays across different platforms can be leveraged across sequential serum samples to provide insight into whether individuals have recently experienced a DENV infection. These methods are applicable to other pathogen systems where multiple serological assays can be leveraged to quantify infection history.
- 25 November 2025
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 21 (11) , e1013708
Open AccessLinking multiple serological assays to infer dengue virus infections from paired samples using mixture models
Dengue virus (DENV) is an increasingly important human pathogen, with already half of the globe’s population living in environments with transmission potential. Since many cases are missed by direct detection methods (RT-PCR or antigen tests), serological assays play an important role in the diagnostic process. However, individual assays can suffer from low sensitivity and specificity and interpreting results from multiple assays remains challenging, particularly because interpretations from multiple assays may differ, creating uncertainty over how to generate finalized interpretations. We develop a Bayesian mixture model that can jointly model data from multiple paired serological assays, to infer infection events. We first test the performance of our model using simulated data. We then apply our model to 677 pairs of acute and convalescent serum collected as a part of illness and household investigations across two longitudinal cohort studies in Kamphaeng Phet, Thailand, including data from 232 RT-PCR confirmed infections (gold standard). We compare the classification of the new model to prior standard interpretations that independently utilize information from either the hemagglutination inhibition assay (HAI) or the enzyme-linked immunosorbent assay (EIA). We find that additional serological assays improve accuracy of infection detection for both simulated and real world data. Models incorporating paired IgG and IgM data as well as those incorporating IgG, IgM, and HAI data consistently have higher accuracy when using PCR confirmed infections as a gold standard (87–90% F1 scores, a combined metric of sensitivity and specificity) than currently implemented cut-point approaches (82–84% F1 scores). Our results provide a probabilistic framework through which multiple serological assays across different platforms can be leveraged across sequential serum samples to provide insight into whether individuals have recently experienced a DENV infection. These methods are applicable to other pathogen systems where multiple serological assays can be leveraged to quantify infection history.
- Open Access
- 31 December 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (1)
Reconciling heterogeneous dengue virus infection risk estimates from different study designs
Uncovering rates at which susceptible individuals become infected with a pathogen, i.e., the force of infection (FOI), is essential for assessing transmission risk and reconstructing distribution of immunity in a population. For dengue, reconstructing exposure and susceptibility statuses from the measured FOI is of particular significance as prior exposure is a strong risk factor for severe disease. FOI can be measured via many study designs. Longitudinal serology is considered gold standard measurements, as they directly track the transition of seronegative individuals to seropositive due to incident infections (seroincidence). Cross-sectional serology can provide estimates of FOI by contrasting seroprevalence across ages. Age of reported cases can also be used to infer FOI. Agreement of these measurements, however, has not been assessed. Using 26 y of data from cohort studies and hospital-attended cases from Kamphaeng Phet province, Thailand, we found FOI estimates from the three sources to be highly inconsistent. Annual FOI estimates from seroincidence were 1.75 to 4.05 times higher than case-derived FOI. Seroprevalence-derived was moderately correlated with case-derived FOI (correlation coefficient = 0.47) with slightly lower estimates. Through extensive simulations and theoretical analysis, we show that incongruences between methods can result from failing to account for dengue antibody kinetics, assay noise, and heterogeneity in FOI across ages. Extending standard inference models to include these processes reconciled the FOI and susceptibility estimates. Our results highlight the importance of comparing inferences across multiple data types to uncover additional insights not attainable through a single data type/analysis.
- 31 December 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (1)
Open AccessReconciling heterogeneous dengue virus infection risk estimates from different study designs
Uncovering rates at which susceptible individuals become infected with a pathogen, i.e., the force of infection (FOI), is essential for assessing transmission risk and reconstructing distribution of immunity in a population. For dengue, reconstructing exposure and susceptibility statuses from the measured FOI is of particular significance as prior exposure is a strong risk factor for severe disease. FOI can be measured via many study designs. Longitudinal serology is considered gold standard measurements, as they directly track the transition of seronegative individuals to seropositive due to incident infections (seroincidence). Cross-sectional serology can provide estimates of FOI by contrasting seroprevalence across ages. Age of reported cases can also be used to infer FOI. Agreement of these measurements, however, has not been assessed. Using 26 y of data from cohort studies and hospital-attended cases from Kamphaeng Phet province, Thailand, we found FOI estimates from the three sources to be highly inconsistent. Annual FOI estimates from seroincidence were 1.75 to 4.05 times higher than case-derived FOI. Seroprevalence-derived was moderately correlated with case-derived FOI (correlation coefficient = 0.47) with slightly lower estimates. Through extensive simulations and theoretical analysis, we show that incongruences between methods can result from failing to account for dengue antibody kinetics, assay noise, and heterogeneity in FOI across ages. Extending standard inference models to include these processes reconciled the FOI and susceptibility estimates. Our results highlight the importance of comparing inferences across multiple data types to uncover additional insights not attainable through a single data type/analysis.
- Open Access
Linking multiple serological assays to infer dengue virus infections from paired samples using mixture models
Dengue virus (DENV) is an increasingly important human pathogen, with already half of the globe’s population living in environments with transmission potential. Since only a minority of cases are captured by direct detection methods (RT-PCR or antigen tests), serological assays play an important role in the diagnostic process. However, individual assays can suffer from low sensitivity and specificity and interpreting results from multiple assays remains challenging, particularly because interpretations from multiple assays may differ, creating uncertainty over how to generate finalized interpretations. We develop a Bayesian mixture model that can jointly model data from multiple paired serological assays, to infer infection events from paired serological data. We first test the performance of our model using simulated data. We then apply our model to 677 pairs of acute and convalescent serum collected as a part of illness and household investigations across two longitudinal cohort studies in Kamphaeng Phet, Thailand, including data from 232 RT-PCR confirmed infections (gold standard). We compare the classification of the new model to prior standard interpretations that independently utilize information from either the hemagglutination inhibition assay (HAI) or the enzyme-linked immunosorbent assay (EIA). We find that additional serological assays improve accuracy of infection detection for both simulated and real world data. Models incorporating paired IgG and IgM data as well as those incorporating IgG, IgM, and HAI data consistently have higher accuracy when using PCR confirmed infections as a gold standard (87-90% F1 scores, a combined metric of sensitivity and specificity) than currently implemented cut-point approaches (82-84% F1 scores). Our results provide a probabilistic framework through which multiple serological assays across different platforms can be leveraged across sequential serum samples to provide insight into whether individuals have recently experienced a DENV infection. These methods are applicable to other pathogen systems where multiple serological assays can be leveraged to quantify infection history.
Open AccessLinking multiple serological assays to infer dengue virus infections from paired samples using mixture models
Dengue virus (DENV) is an increasingly important human pathogen, with already half of the globe’s population living in environments with transmission potential. Since only a minority of cases are captured by direct detection methods (RT-PCR or antigen tests), serological assays play an important role in the diagnostic process. However, individual assays can suffer from low sensitivity and specificity and interpreting results from multiple assays remains challenging, particularly because interpretations from multiple assays may differ, creating uncertainty over how to generate finalized interpretations. We develop a Bayesian mixture model that can jointly model data from multiple paired serological assays, to infer infection events from paired serological data. We first test the performance of our model using simulated data. We then apply our model to 677 pairs of acute and convalescent serum collected as a part of illness and household investigations across two longitudinal cohort studies in Kamphaeng Phet, Thailand, including data from 232 RT-PCR confirmed infections (gold standard). We compare the classification of the new model to prior standard interpretations that independently utilize information from either the hemagglutination inhibition assay (HAI) or the enzyme-linked immunosorbent assay (EIA). We find that additional serological assays improve accuracy of infection detection for both simulated and real world data. Models incorporating paired IgG and IgM data as well as those incorporating IgG, IgM, and HAI data consistently have higher accuracy when using PCR confirmed infections as a gold standard (87-90% F1 scores, a combined metric of sensitivity and specificity) than currently implemented cut-point approaches (82-84% F1 scores). Our results provide a probabilistic framework through which multiple serological assays across different platforms can be leveraged across sequential serum samples to provide insight into whether individuals have recently experienced a DENV infection. These methods are applicable to other pathogen systems where multiple serological assays can be leveraged to quantify infection history.
- Open Access
Identifying the role of household immunity in driving individual dengue virus infection risk
Dengue virus (DENV) infection risk is known to vary substantially, even across small communities, with infections in and around the home driving transmission. However, It remains unclear how the immune status of an individual or household dictate this risk in part due to transmission being dominated by subclinical infections. In this study, we used demographic, household characteristic, and serological data from a multigenerational cohort study of 2860 individuals from 470 households in Kamphaeng Phet, Thailand, to determine the incidence and risk factors for DENV infections. We used hemagglutination inhibition (HAI) antibody titers measured in sequential serum samples to identify subclinical infections through a gradient boosted regression model. This approach identified ∼10% more cases than commonly used methods with approximately 90% of all infections being subclinical. As expected, we found that having higher DENV antibody titers was protective against infection. Individuals were additionally protected if other household members had higher titers suggesting that there are indirect effects of household immunity on the individuals found within a household. Our study provides a framework for inferring subclinical infections and characterizing the epidemiology of DENV infection in households.
Open AccessIdentifying the role of household immunity in driving individual dengue virus infection risk
Dengue virus (DENV) infection risk is known to vary substantially, even across small communities, with infections in and around the home driving transmission. However, It remains unclear how the immune status of an individual or household dictate this risk in part due to transmission being dominated by subclinical infections. In this study, we used demographic, household characteristic, and serological data from a multigenerational cohort study of 2860 individuals from 470 households in Kamphaeng Phet, Thailand, to determine the incidence and risk factors for DENV infections. We used hemagglutination inhibition (HAI) antibody titers measured in sequential serum samples to identify subclinical infections through a gradient boosted regression model. This approach identified ∼10% more cases than commonly used methods with approximately 90% of all infections being subclinical. As expected, we found that having higher DENV antibody titers was protective against infection. Individuals were additionally protected if other household members had higher titers suggesting that there are indirect effects of household immunity on the individuals found within a household. Our study provides a framework for inferring subclinical infections and characterizing the epidemiology of DENV infection in households.